Cargando…
Targeting c-Myc with a novel Peptide Nuclear Delivery Device
Biologics such as peptides and antibodies are a well-established class of therapeutics. However, their intracellular delivery remains problematic. In particular, methods to efficiently inhibit intra-nuclear targets are lacking. We previously described that Pseudomonas Exotoxin A reaches the nucleopl...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576588/ https://www.ncbi.nlm.nih.gov/pubmed/33082422 http://dx.doi.org/10.1038/s41598-020-73998-x |